Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 98.00 | |
2 mg | In stock | $ 146.00 | |
5 mg | In stock | $ 211.00 | |
10 mg | In stock | $ 333.00 | |
25 mg | In stock | $ 597.00 | |
50 mg | In stock | $ 852.00 | |
100 mg | In stock | $ 1,170.00 |
Description | Bortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib. |
In vivo | Bortezomib-pinanediol (BP)-loaded HA-CCMs exhibit markedly enhanced toleration, broadened therapeutic window, and significantly more effective growth suppression of CD44-overexpressed multiple myeloma in nude mice than free bortezomib.?Lipophilized BTZ-loaded HA-CCMs has opened a new avenue for targeted bortezomib therapy of multiple myeloma. |
Molecular Weight | 518.46 |
Formula | C29H39BN4O4 |
CAS No. | 205393-22-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.87 mg/mL (5.53 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bortezomib-pinanediol 205393-22-2 Proteases/Proteasome Ubiquitination Proteasome Bortezomibpinanediol Bortezomib pinanediol inhibitor inhibit